E-DRUG: Invitation to MSF Satellite Event at ICASA 2005
------------------------------------------------
(Abuja, Nigeria) -- Sunday, December 4
[The proceedings of this meeting could be of interest to e-druggers. Rachel, could they be made available please ? BS]
ALIVE AFTER FIVE YEARS - ANTIRETROVIRAL TREATMENT (ART)
IN RESOURCE-POOR SETTINGS
Sunday, December 4th, 2005, from 11h00-15h00
At the International Conference Centre, Prefab 1(ICC 3)
PROGRAMME
11:00 Welcome by Dr Roger Teck, MSF
PART ONE:
EXPERIENCES FROM AFRICAN HIV TREATMENT PROGRAMMES
11:05 Long-term Treatment: Outcomes and Challenges
What happens when first-line medicines no longer work?
Short presentations followed by open discussion.
-- Pushing for ART in Cameroon
Isaac Tita, HIV/AIDS Activist
How did Cameroon bring ART to patients?
-- Long-term outcomes in adults under ART
in resource-poor settings
Dr Pierre Humblet, Coordinator of the MSF HIV/AIDS Working Group
Three-year treatment outcomes in patients under ART in MSF programmes
-- Challenges in providing long-term ART:
The experience of Khayelitsha, South Africa
Dr Eric Goemaere, Head of mission, MSF South Africa
Long-term treatment outcomes in the Khayelitsha programme: What are the
challenges around adherence? When to switch to second-line treatment? How
to access affordable second-line treatments?
-- Cost implications of new drugs and increased need for monitoring
Fernando Pascual, pharmacist, and Daniel Berman, coordinator, MSF Campaign
for Access to Essential Medicines
Gaining access to newer drugs (especially second-line) and monitoring
tools: challenges and cost implications.
11:45 Open Discussion
12:30 The Challenge of Increasing Access to Treatment for Children
This session is very short but participants are invited to attend the
abstract sessions where results from MSF's programmes treating children
will be presented.
-- Main obstacles to scaling up paediatric ART
Dr Felipe Garcia, AIDS physician, MSF Campaign for Access to Essential
Medicines
"Babies with AIDS: No tests, no pills - no future?" 8-minute film
PART TWO: STRATEGIES TO REACH MORE PEOPLE
13:15 Decentralization / Simplification of ART Delivery
-- Impact of cost sharing on access to care in DRC and Malawi: MSF's
experience with financial barriers
Dr Mit Philips from MSF's Analysis and Advocacy Unit, Brussels
-- Decentralization of ART in a rural district in Malawi: the MSF
experience in Thyolo
Dr Roger Teck, former MSF Head of mission in Thyolo
-- The challenge of decentralization and rationalization of resources:
MSF's experience in Homa Bay (Kenya)
Dr Bintari Dwihardiani, former HIV coordinator for MSF in Homa Bay, now
medical coordinator
14:00 Open Discussion
14:30 The Nigerian Context
-- Access to ART in Nigeria: MSF's experience in Lagos
Els Botha Standaert, coordinator of the MSF project in Lagos
-- Role and place of PLHA groups and associations in access to treatment
and treatment delivery in Nigeria
`Rolake Odetoyinbo, coordinator for Treatment Action Movement (TAN), a
coalition of Nigerian NGOs working on access to treatment.
14:55 Conclusion
---
Rachel M. Cohen
U.S. Director, Campaign for Access to Essential Medicines
Doctors Without Borders/Médecins Sans Frontières (MSF)
333 Seventh Avenue, 2nd Floor * New York, NY * 10001-5004 * USA
Tel: +1-212-655-3762
Mobile: +1-917-331-9077
Fax: +1-212-679-7016
E-mail: rachel.cohen@newyork.msf.org
http://www.doctorswithoutborders.org/
http://www.accessmed-msf.org/